CAR T-cell therapy has revolutionized the treatment of certain blood cancers — including leukemias, lymphomas and multiple myeloma. CAR T-cells are genetically enhanced versions of a patient’s own ...
The therapy has a high rate of relapse, even in patients who first achieve complete remission. Now, a novel approach is helping to keep patients’ cancer-free for longer.
Discover the latest hospital construction projects, including a $5 billion pediatric campus and a $1.5 billion cancer hospital, aimed at improving access to on ...
Oncologists experience high levels of burnout and compassion fatigue. Previously, levels were around 35%. 1 In a recent survey, 59% of respondents reported 1 or more symptoms of burnout: 57% reported ...
CancerX announced today the launch of its 2025 Accelerator cohort, which will focus on transforming digital innovation and AI solutions in cancer care. This year, CancerX is partnering with KidsX, a ...